Published in J Virol on July 01, 1981
Structure of the FMDV translation initiation site and of the structural proteins. Nucleic Acids Res (1983) 2.58
VPg gene amplification correlates with infective particle formation in foot-and-mouth disease virus. J Virol (1992) 1.10
An RNA virus hijacks an incognito function of a DNA repair enzyme. Proc Natl Acad Sci U S A (2012) 1.08
Engineered picornavirus VPg-RNA substrates: analysis of a tyrosyl-RNA phosphodiesterase activity. PLoS One (2011) 0.87
Modification of picornavirus genomic RNA using 'click' chemistry shows that unlinking of the VPg peptide is dispensable for translation and replication of the incoming viral RNA. Nucleic Acids Res (2013) 0.82
Divergent Requirement for a DNA Repair Enzyme during Enterovirus Infections. MBio (2015) 0.79
Sequence and phylogenetic analysis of the non-structural 3A and 3B protein-coding regions of foot-and-mouth disease virus subtype A Iran 05. J Vet Sci (2010) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Covalent linkage of a protein to a defined nucleotide sequence at the 5'-terminus of virion and replicative intermediate RNAs of poliovirus. Proc Natl Acad Sci U S A (1977) 8.12
A protein covalently linked to poliovirus genome RNA. Proc Natl Acad Sci U S A (1977) 7.92
The location of the polio genome protein in viral RNAs and its implication for RNA synthesis. Nature (1977) 5.61
O4-(5'-uridylyl)tyrosine is the bond between the genome-linked protein and the RNA of poliovirus. Proc Natl Acad Sci U S A (1978) 4.68
Protein is linked to the 5' end of poliovirus RNA by a phosphodiester linkage to tyrosine. J Biol Chem (1978) 4.17
The 5'-terminal structures of poliovirion RNA and poliovirus mRNA differ only in the genome-linked protein VPg. Proc Natl Acad Sci U S A (1977) 3.97
5'-Terminal nucleotide sequences of polio virus polyribosomal RNA and virion RNA are identical. Nature (1977) 3.00
Protein covalently linked to foot-and-mouth disease virus RNA. Nature (1977) 2.35
Location of the initiation site for protein synthesis on foot-and-mouth disease virus RNA by in vitro translation of defined fragments of the RNA. J Virol (1980) 2.34
The genome of poliovirus is an exceptional eukaryotic mRNA. Prog Nucleic Acid Res Mol Biol (1976) 1.99
More precise location of the polycytidylic acid tract in foot and mouth disease virus RNA. J Virol (1978) 1.69
An enzymatic activity in uninfected cells that cleaves the linkage between poliovirion RNA and the 5' terminal protein. Cell (1978) 1.69
Encephalomyocarditis virus RNA. III. Presence of a genome-associated protein. J Virol (1978) 1.59
Heterogeneity of the genome-linked protein of foot-and-mouth disease virus. J Virol (1980) 1.50
Purification and properties of a HeLa cell enzyme able to remove the 5'-terminal protein from poliovirus RNA. J Biol Chem (1980) 1.28
Protein-linked RNA of poliovirus is competent to form an initiation complex of translation in vitro. Nature (1980) 1.13
The nucleotide sequence at the 5' end of foot and mouth disease virus RNA. Nucleic Acids Res (1979) 1.13
The structure of the covalent linkage between proteins and RNA in encephalomyocarditis virus. Nucleic Acids Res (1980) 1.01
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain (1988) 18.17
Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol (1998) 9.32
Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. J Natl Cancer Inst (1999) 6.60
Dynamic nuclear polarization at 9T using a novel 250GHz gyrotron microwave source. J Magn Reson (2003) 6.46
The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution. Nature (1989) 5.87
Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr (2001) 5.74
Classification of rhabdovirus proteins: a proposal. J Virol (1972) 5.54
Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis (2000) 5.52
Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature (1982) 5.50
Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. J Natl Cancer Inst (1996) 5.28
Myristylation of picornavirus capsid protein VP4 and its structural significance. Nature (1987) 5.26
Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial. J Natl Cancer Inst (2001) 4.84
O4-(5'-uridylyl)tyrosine is the bond between the genome-linked protein and the RNA of poliovirus. Proc Natl Acad Sci U S A (1978) 4.68
Unique features of internal initiation of hepatitis C virus RNA translation. EMBO J (1995) 4.44
Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer. J Natl Cancer Inst (1997) 4.32
Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature (1985) 3.97
The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid). J Gen Virol (1989) 3.53
The proteins of biologically active sub-units of vesicular stomatitis virus. J Gen Virol (1970) 3.44
Propranolol as ocular hypotensive agent. Br J Ophthalmol (1967) 3.42
Comparison of human stromelysin and collagenase by cloning and sequence analysis. Biochem J (1986) 3.31
Multi-disciplinary clinical study of Smith-Magenis syndrome (deletion 17p11.2) Am J Med Genet (1996) 3.17
An infectious molecular clone of a Japanese genotype 1b hepatitis C virus. Hepatology (1999) 3.00
The complete nucleotide sequence of the RNA coding for the primary translation product of foot and mouth disease virus. Nucleic Acids Res (1984) 3.00
Human pharmacokinetic and pharmacodynamic studies on the atenolo (ICI 66,082), a new cardioselective beta-adrenoceptor blocking drug. Br J Clin Pharmacol (1976) 2.99
A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am J Hum Genet (1999) 2.88
erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer. J Natl Cancer Inst (1998) 2.85
Dissection of vesicular stomatitis virus into the infective ribonucleoprotein and immunizing components. J Gen Virol (1970) 2.85
Fusion protein of the paramyxovirus simian virus 5: nucleotide sequence of mRNA predicts a highly hydrophobic glycoprotein. Proc Natl Acad Sci U S A (1984) 2.82
The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II. Clin Infect Dis (2000) 2.79
A highly conserved amino-acid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite. Nature (1988) 2.70
Serological relationships between different strains of vesicular stomatis virus. J Gen Virol (1972) 2.68
The complete amino acid sequence of human complement factor H. Biochem J (1988) 2.63
Kinetic tuning of myosin via a flexible loop adjacent to the nucleotide binding pocket. J Biol Chem (1998) 2.62
Assignment of the genome segments of bluetongue virus type 1 to the proteins which they encode. Virology (1984) 2.60
The ribonucleic acids of the infective and interfering components of vesicular stomatitis virus. J Gen Virol (1967) 2.57
Chemical basis of antigenic variation in foot-and-mouth disease virus. Nature (1984) 2.52
Genetically engineered foot-and-mouth disease viruses with poly(C) tracts of two nucleotides are virulent in mice. J Virol (1993) 2.50
Internal initiation of translation of hepatitis C virus RNA: the ribosome entry site is at the authentic initiation codon. RNA (1996) 2.45
Classification of peste des petits ruminants virus as the fourth member of the genus Morbillivirus. Intervirology (1979) 2.43
A survey to identify the clinical coding and classification systems currently in use across Europe. Stud Health Technol Inform (2001) 2.41
3'-Terminal nucleotide sequences in the genome RNA of picornaviruses. Nature (1978) 2.40
Protein covalently linked to foot-and-mouth disease virus RNA. Nature (1977) 2.35
Location of the initiation site for protein synthesis on foot-and-mouth disease virus RNA by in vitro translation of defined fragments of the RNA. J Virol (1980) 2.34
An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc Natl Acad Sci U S A (2001) 2.28
Proteinase inhibitor II from potatoes: isolation and characterization of its protomer components. Biochemistry (1976) 2.27
All foot and mouth disease virus serotypes initiate protein synthesis at two separate AUGs. Nucleic Acids Res (1987) 2.22
Characterisation of a rotavirus.20b. Nature (1975) 2.21
HIV-associated nephropathy in transgenic mice expressing HIV-1 genes. Virology (1991) 2.16
Synthesis of calf prochymosin (prorennin) in Escherichia coli. Proc Natl Acad Sci U S A (1983) 2.13
A physico-chemical sub-grouping of the mammalian picornaviruses. J Gen Virol (1973) 2.08
A re-appraisal of the biochemical map of foot-and-mouth disease virus RNA. J Gen Virol (1978) 2.06
The replication of picornaviruses. J Gen Virol (1979) 2.03
Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein. Nature (1987) 2.00
Poly(C) in animal viral RNAs. Nature (1974) 1.95
Sequence and location of the poly C tract in aphtho- and cardiovirus RNA. Nucleic Acids Res (1979) 1.95
The cloning and nucleotide sequence of cDNA for an amplified glutamine synthetase gene from the Chinese hamster. Nucleic Acids Res (1986) 1.95
Benchmarks of fairness for health care reform: a policy tool for developing countries. Bull World Health Organ (2000) 1.94
Model for vesicular stomatitis virus. J Virol (1972) 1.92
Infective virus substructure from vesicular stomatitis virus. J Virol (1967) 1.89
The antigens of vesicular stomatitis virus. I. Separation and immunogenicity of three complement-fixing components. J Immunol (1966) 1.89
Analysis and gene assignment of mRNAs of a paramyxovirus, simian virus 5. Virology (1984) 1.88
Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus. Nature (1990) 1.86
HER2 and choice of adjuvant chemotherapy for invasive breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-15. J Natl Cancer Inst (2000) 1.85
Surface structure of vesicular stomatitis virus. J Gen Virol (1969) 1.82
The nucleotide sequence of cDNA coding for the structural proteins of foot-and-mouth disease virus. Gene (1982) 1.82
Further physicochemical characterization of Nodamura virus. Evidence that the divided genome occurs in a single component. J Gen Virol (1978) 1.78
Molecular cloning and nucleotide sequence of cDNA coding for calf preprochymosin. Nucleic Acids Res (1982) 1.75
A foot and mouth disease syndrome in pigs caused by an enterovirus. Nature (1968) 1.74
Molecular cloning of foot and mouth disease virus genome and nucleotide sequences in the structural protein genes. Nature (1981) 1.73
Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16. Gastroenterology (1998) 1.73
Antibody-complexed foot-and-mouth disease virus, but not poliovirus, can infect normally insusceptible cells via the Fc receptor. Virology (1993) 1.72
Diazoxide in treatment of primary pulmonary hypertension. Br Heart J (1978) 1.71
Effect of cold ischemia time on the early outcome of human hepatic allografts preserved with UW solution. Transplantation (1991) 1.71
More precise location of the polycytidylic acid tract in foot and mouth disease virus RNA. J Virol (1978) 1.69
Adjuvant therapy for very young women with breast cancer: need for tailored treatments. J Natl Cancer Inst Monogr (2001) 1.67
Presence of a covalently linked protein on calicivirus RNA. J Gen Virol (1978) 1.66